Inhibrx, Inc. Annual Operating Income (Loss) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Inhibrx, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2023.
  • Inhibrx, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$73.8M, a 68.7% decline year-over-year.
  • Inhibrx, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$249M, a 73.3% decline year-over-year.
  • Inhibrx, Inc. annual Operating Income (Loss) for 2023 was -$219M, a 69.8% decline from 2022.
  • Inhibrx, Inc. annual Operating Income (Loss) for 2022 was -$129M, a 68.6% decline from 2021.
  • Inhibrx, Inc. annual Operating Income (Loss) for 2021 was -$76.6M, a 13.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$219M -$90.1M -69.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 -$129M -$52.6M -68.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 -$76.6M -$9.12M -13.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-06
2020 -$67.4M -$23.7M -54.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-28
2019 -$43.7M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.